Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1418160-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 7
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI M701TVIL1418160J1), received between Jan 2, 2019 and May 9, 2024 — classified as 7 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information4
- Complete Blockage3
- Adverse Event Without Identified Device or Use Problem1
- Improper or Incorrect Procedure or Method1
- Lack of Effect1
- Malposition of Device1
- Material Puncture/Hole1
- Migration1
Patient problems
- Failure of Implant6
- Occlusion2
- Aneurysm1
- Clinical Endoleak1
- Thrombosis1
- Thrombus1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryMay 9, 2024Lack of Effect; Lack of Effect
THE PATIENT WAS IMPLANTED WITH THE OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2019. ON APRIL 18, 2024, IT WAS REPORTED THAT A POSSIBLE TYPE 1B ENDOLEAK WAS IDENTIFIED. ON (B)(6) 2024, THE PATIENT UNDERWENT A RE-INTERVENTION, DURING WHICH THE PHYSICIAN ELECTED TO IMPLANT TWO (2) OVATION IX ILIAC LIMBS, WITH ONE OF THE LIMBS BEING EXTENDED DOWN INTO THE RIGHT EXTERNAL ILIAC ARTERY.
Patient problems: Clinical Endoleak
MAUDE report 19280488 ↗InjuryJun 2, 2021Complete Blockage; Insufficient Device Problem Information; Complete Blockage; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH A ALTO MAIN BODY AND TWO (2) ILIAC LIMB STENT GRAFTS TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). NOW APPROXIMATELY ONE MONTH POST INITIAL PROCEDURE DURING A FOLLOW UP VISIT THE PATIENT WAS IDENTIFIED WITH A OCCLUDED RIGHT ILIAC LIMB. THE PHYSICIAN ELECTED TO RESOLVE THE OCCLUSION WITH A THROMBECTOMY BALLOON AND PLACE FOUR ILIAC LIMBS. PATIENT IS CURRENTLY BEING MONITORED AND DOING WELL.
Patient problems: Failure of Implant
MAUDE report 11925291 ↗InjuryNov 24, 2020Insufficient Device Problem Information; Migration; Insufficient Device Problem Information; Migration
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM AND TWO (2) OVATION IX ILIAC LIMBS TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY THREE (3) MONTHS POST INITIAL PROCEDURE A TYPE 1B ENDOLEAK WAS IDENTIFIED DURING A SCAN. THE PATIENT WAS REPORTED TO BE STABLE. RE-INTERVENTION WAS COMPLETED WITH IMPLANT OF AN ADDITIONAL OVATION IX ILIAC LIMB. REPORTEDLY THE PROCEDURE WENT WELL. THE FINAL PATIENT STATUS WAS REPORTED TO BE GOOD.
Patient problems: Failure of Implant
MAUDE report 10889927 ↗InjuryAug 18, 2020Complete Blockage; Insufficient Device Problem Information; Complete Blockage; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY 1 YEAR POST PROCEDURE, THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH A COLD LEG. PHYSICIAN ELECTED TO ADMINISTER A LYTIC AND PERFORM AN ANGIO-JET. PHYSICIAN NOTICED THE LEFT ILIAC LIMB WAS HIGHER THAN THE RIGHT AND PHYSICIAN THOUGHT IT WAS IMPEDING FLOW INTO THAT LIMB. PHYSICIAN ELECTED TO EXTEND THE LIMB TO MATCH THE OTHER SIDE AND PUT A SECOND STENT TO TRAP ANY ADDITIONAL THROMBUS LEFT. FINAL ANGIO LOOKED GREAT AND PATIENT WAS DISCHARGED. ADDITIONAL INFORMATION: DURING CLINICAL ASSESSMENT, OCCLUSION OF THE LEFT LIMB WAS ALSO IDENTIFIED THAT WAS NOT INCLUDED IN THE EVENT AS REPORTED.
Patient problems: Failure of Implant; Occlusion; Thrombosis; Thrombus
MAUDE report 10423685 ↗InjuryApr 27, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY FOUR (4) YEARS POST INITIAL PROCEDURE, A TYPE 1B ENDOLEAK ON THE LEFT SIDE WAS IDENTIFIED BY A COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA). THE PATIENT IS CURRENTLY BEING MONITORED WHILE AWAITING AN INTERVENTION. ADDITIONAL INFORMATION: RE-INTERVENTION COMPLETED ON (B)(6) 2020. THE PHYSICIAN ELECT TO IMPLANT AN OVATION IX ILIAC LIMB TO TREAT THIS EVENT. THE PATIENTS STATUS WAS NOT PROVIDED.
Patient problems: Failure of Implant
MAUDE report 10003068 ↗InjuryApr 30, 2019Material Puncture/Hole; Adverse Event Without Identified Device or Use Problem; Material Puncture/Hole; Adverse Event Without Identified Device or Use Problem
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. APPROXIMATELY TWO (2) YEARS POST INITIAL PROCEDURE, DURING COILING OF A TYPE 2 ENDOLEAK WITH SAC GROWTH (NON-DEVICE RELATED FAILURE) A POSSIBLE TYPE 3B ENDOLEAK OF THE LEFT LIMB WAS IDENTIFIED. AN ANGIOGRAM WAS PERFORMED; HOWEVER, INCONCLUSIVE. THE PHYSICIAN ELECTED TO RELINE THE ORIGINAL LIMB WITH ANOTHER OVATION IX LIMB. THE SUBSEQUENT ANGIOGRAM SHOWED CONCLUSIVELY THAT THE POSSIBLE TYPE 3B ENDOLEAK WAS RESOLVED. REPORTEDLY, THE PATIENT WAS FANTASTIC POST RE-INTERVENTION AND WAS TO BE DISCHARGED THE MORNING AFTER.
Patient problems: Aneurysm; Failure of Implant
MAUDE report 8567039 ↗InjuryJan 2, 2019Complete Blockage; Improper or Incorrect Procedure or Method; Malposition of Device; Complete Blockage; Improper or Incorrect Procedure or Method; Malposition of Device
THE PATIENT WAS INITIALLY TREATED WITH OVATION IX TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT PRESENTED APPROXIMATELY 1-MONTH POST-OP WITH LEFT LEG CLAUDICATION. A CTA SCAN REVEALED A TOTAL OCCLUSION OF THE LEFT ILIAC LIMB STENT GRAFT. THE PHYSICIAN IS PLANNING TO TREAT THE PATIENT BY FEM-FEM BYPASS- RIGHT COMMON FEM TO LEFT COMMON FEM. THE TREATMENT HAS NOT YET BEEN SCHEDULED. THE CURRENT PATIENT CONDITION WAS NOT INITIALLY REPORTED.
Patient problems: Failure of Implant; Occlusion
MAUDE report 8210923 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page